Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores

Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores

Design of clinical trials requires careful decision-making across several dimensions, including endpoints, eligibility criteria, and subgroup enrichment. Clinical trial simulation can be an informative tool in trial design, providing empirical evidence by which to evaluate and compare the results of...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Weinstein, SM, Coates, LC, Helliwell, PS, Ogdie, A, Stephens-Shields, AJ
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	SAGE Publications 2021

Gelijkaardige items

Psoriatic arthritis: prospects for the future
door: Hackett, S, et al.
Gepubliceerd in: (2022)

Measuring outcomes in psoriatic arthritis
door: Ogdie, A, et al.
Gepubliceerd in: (2020)

THE DIAGNOSIS OF PSORIATIC ARTHRITIS
door: P.S. Helliwell
Gepubliceerd in: (2011-09-01)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
door: Helliwell, PS, et al.
Gepubliceerd in: (2022)

What should be the primary target of "treat to target" in psoriatic arthritis?
door: Coates, LC, et al.
Gepubliceerd in: (2018)

Psoriatic arthritis: prospects for the future
door: Simon Hackett, et al.
Gepubliceerd in: (2022-03-01)

Psoriatic arthritis
door: FitzGerald, O, et al.
Gepubliceerd in: (2021)

Comparing the visual analogue scale and the numerical rating scale in patient-reported outcomes in psoriatic arthritis
door: Ye, W, et al.
Gepubliceerd in: (2021)

Inhibition of interleukin-17 in patients with oligoarticular psoriatic arthritis
door: Ogdie, A, et al.
Gepubliceerd in: (2023)

The role of ultrasound in psoriatic arthritis — do we need a score?
door: D'Agostino, MA, et al.
Gepubliceerd in: (2019)

Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis
door: Coates, LC, et al.
Gepubliceerd in: (2022)

Measuring physical function in psoriatic arthritis: comparing the Multi-Dimensional Health Assessment Questionnaire to the Health Assessment Questionnaire Disability Index
door: Ye, W, et al.
Gepubliceerd in: (2021)

Current concepts and unmet needs in psoriatic arthritis
door: Mahmood, F, et al.
Gepubliceerd in: (2017)

Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
door: Coates, L, et al.
Gepubliceerd in: (2019)

Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
door: Helliwell, PS, et al.
Gepubliceerd in: (2021)

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
door: Coates, L, et al.
Gepubliceerd in: (2020)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
door: Coates, L, et al.
Gepubliceerd in: (2016)

Outcome measures in psoriatic arthritis: where next?
door: Hackett, S, et al.
Gepubliceerd in: (2022)

Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis
door: Laure Gossec, et al.
Gepubliceerd in: (2024-02-01)

Assessing disease activity in psoriatic arthritis: a literature review
door: Tucker, L, et al.
Gepubliceerd in: (2018)

The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study
door: Helliwell, PS, et al.
Gepubliceerd in: (2023)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
door: Gladman, DD, et al.
Gepubliceerd in: (2022)

Classification and outcome measures for psoriatic arthritis
door: Leung, Y, et al.
Gepubliceerd in: (2018)

Hot topice debate: preventing psoriatic arthritis in patients with psoriasis
door: Vivekanantham, A, et al.
Gepubliceerd in: (2024)

Sex-specific differences in patients with psoriatic arthritis: a systematic review
door: Coates, LC, et al.
Gepubliceerd in: (2022)

Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review
door: Leung, Y-Y, et al.
Gepubliceerd in: (2020)

Outcomes of the 2019 GRAPPA workshop on continuous composite indices for the assessment of psoriatic arthritis and membership: Recommended next steps
door: Tillett, W, et al.
Gepubliceerd in: (2020)

How should we define disease and outcomes in axial psoriatic arthritis?
door: Coates, LC
Gepubliceerd in: (2021)

Identification of psoriatic arthritis in patients with psoriasis
door: Coates, LC, et al.
Gepubliceerd in: (2023)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
door: Soriano, ER, et al.
Gepubliceerd in: (2023)

The State of the Art - Psoriatic Arthritis outcome assessment in clinical trials and daily practice
door: Day, J, et al.
Gepubliceerd in: (2022)

New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation
door: Coates, L, et al.
Gepubliceerd in: (2016)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
door: Atul Deodhar, et al.
Gepubliceerd in: (2022-07-01)

Psoriatic Arthritis: A Review
door: Farrouq Mahmood, et al.
Gepubliceerd in: (2016-07-01)

Obesity and Psoriatic Arthritis: A Narrative Review
door: Anand Kumthekar, et al.
Gepubliceerd in: (2020-06-01)

Classification and Outcome Measures for Psoriatic Arthritis
door: Ying Ying Leung, et al.
Gepubliceerd in: (2018-09-01)

Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis
door: Alexis Ogdie, et al.
Gepubliceerd in: (2023-05-01)

Psoriatic arthritis in developing and resource-poor countries
door: Maharaj, AB, et al.
Gepubliceerd in: (2020)

Methotrexate in psoriasis and psoriatic arthritis
door: Coates, L, et al.
Gepubliceerd in: (2020)

GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies
door: Tillett, W, et al.
Gepubliceerd in: (2017)